CCR6-expressing cells are thought to play a major role in a number of Th17-mediated autoimmune diseases including T1D, psoriasis and RA and targeting these cells or the cytokines they produce is an area of active clinical trial activity (52, 53). Here, CCR6 is linked to rheumatoid arthritis.